COLO-IG
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

COLO-IG Trademark

Serial Number: 79408938 • Registration: 8072653

COLO-IG is a trademark filed by BIOCHEM Zusatzstoffe Handels- und Produktionsgesellschaft mbH on October 2, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

BIOCHEM Zusatzstoffe Handels- und Produktionsgesellschaft mbH (18 trademarks)

Küstermeyerstr. 16

Entity Type: 16

Trademark Details

Filing Date

October 2, 2024

Registration Date

December 23, 2025

Published for Opposition

November 4, 2025

Goods & Services

Dietary supplements for animals; medicated animal feed.

Animal foodstuffs.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 23, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 6, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 6, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 23, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 23, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2025 TROA
ASSIGNED TO EXAMINER
Jun 2, 2025 DOCK
REFUSAL PROCESSED BY IB
May 24, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 5, 2025 RFCS
REFUSAL PROCESSED BY MPU
May 5, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 19, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 8, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 7, 2024 REPR